Cal-Maine Foods reported second-quarter earnings per share of $2.13, surpassing analyst forecasts of $2.01, but generated $769.5 million in sales versus an expected $826.4 million. The stock declined 4.1% on the trading day of the release as investors weighed the profit beat against a nearly 19% year-over-year revenue decline driven by lower conventional egg pricing.

Sales of specialty egg varieties—including organic and free-range offerings—held relatively steady compared with a 41% plunge in conventional egg revenues. CEO Sherman Miller attributed the segment’s performance to sustained consumer demand and called the specialty business a ‘‘source of resilience’’ that helped offset historic price contractions in the broader egg market.

Analysts project full-year earnings to drop from a record near $25 per share in 2025 to approximately $9.31 in 2026, with further declines to $6.67 by 2028. At those forward estimates the shares trade around 11.5 times earnings two years out, roughly in line with the company’s double-digit dividend yield. Investors will assess whether the current valuation appropriately reflects the earnings downturn and stability provided by the specialty segment.